JenRz

ESPR expect further downside

Short
JenRz Updated   
NASDAQ:ESPR   Esperion Therapeutics, Inc.
I just started playing with FDA approvals using my pendulum. I don't see anything good coming out of this news event other than a bounce to sell into.
Symmetry support is $57.15 held once. Will it twice??
If it doesn't hold this 786 fib (53.99), the door is open to $40.
Comment:
I'm looking for $42-43 on this one.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.